Chemical company Oxea today announced that after a construction period of approximately one year it has successfully started up its new unit “Ester 2” for the production of specialty esters in Oberhausen, Germany. This new facility will boost Oxea’s production capacity for specialty esters by over 50 percent. Oxea is currently producing specialty esters in three units worldwide, with a fourth being under construction in China.
The specialty esters product range consists of phthalate-free and non-VOC Oxsoft products such as 3G8, DOA, GPO, TOTM Duo 1 and Duo 2 as well as 3NG810 und Oxfilm 351. Oxea supplies these products to customers operating in growth sectors in medical technology, food cling wraps, the automotive industry and architecture, among others.
“With our new unit, we are addressing the increasing demand for specialty esters made by Oxea. This successful investment further improves our flexibility and delivery capacity,” said Miguel Mantas, responsible for Sales and Marketing within Oxea’s Executive Board.
“The startup of Ester 2 brings us one big step closer to achieving our strategic goal. We continue to evolve into a supplier of specialty chemicals and are investing in our future,” said Dr. Martina Flöel, spokesperson for the Executive Board of Oxea.
Oxea is a global manufacturer of oxo intermediates and oxo derivatives, such as alcohols, polyols, carboxylic acids, specialty esters, and amines. These products are used for the production of high-quality coatings, lubricants, cosmetics and pharmaceutical products, flavorings and fragrances, printing inks and plastics. In 2011, Oxea generated revenue of about EUR 1.5 billion with its 1,365 employees in Europe, the Americas and Asia. For more information on Oxea, please go to: www.oxea-chemicals.com.